

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 8.25165788 |
| 2 | protein neddylation (GO:0045116) | 8.12664183 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 7.30864239 |
| 4 | adenosine receptor signaling pathway (GO:0001973) | 6.99556628 |
| 5 | regulation of platelet aggregation (GO:0090330) | 6.14932959 |
| 6 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 6.09480821 |
| 7 | regulation of platelet activation (GO:0010543) | 5.74955338 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.62170089 |
| 9 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.59695660 |
| 10 | blood coagulation, intrinsic pathway (GO:0007597) | 5.42578488 |
| 11 | platelet aggregation (GO:0070527) | 5.26368934 |
| 12 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.21668625 |
| 13 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.20558380 |
| 14 | negative regulation of norepinephrine secretion (GO:0010700) | 4.93990349 |
| 15 | positive regulation of mast cell activation (GO:0033005) | 4.71047802 |
| 16 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.64411374 |
| 17 | megakaryocyte development (GO:0035855) | 4.61091491 |
| 18 | negative regulation of platelet activation (GO:0010544) | 4.57087560 |
| 19 | lipoxygenase pathway (GO:0019372) | 4.55288130 |
| 20 | purinergic receptor signaling pathway (GO:0035587) | 4.53088773 |
| 21 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.50490099 |
| 22 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.42236024 |
| 23 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.37668361 |
| 24 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 4.30901055 |
| 25 | angiogenesis involved in wound healing (GO:0060055) | 4.30438922 |
| 26 | neutrophil activation (GO:0042119) | 4.26016675 |
| 27 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.22621782 |
| 28 | regulation of lipoprotein metabolic process (GO:0050746) | 4.22401698 |
| 29 | negative regulation of heart rate (GO:0010459) | 4.17976113 |
| 30 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.15685650 |
| 31 | regulation of integrin activation (GO:0033623) | 4.12534853 |
| 32 | negative regulation of protein localization to cell surface (GO:2000009) | 4.08458064 |
| 33 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01338389 |
| 34 | platelet degranulation (GO:0002576) | 3.94456730 |
| 35 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.87348080 |
| 36 | granulocyte activation (GO:0036230) | 3.86359239 |
| 37 | platelet formation (GO:0030220) | 3.85285387 |
| 38 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.75713287 |
| 39 | positive regulation of macrophage differentiation (GO:0045651) | 3.66027257 |
| 40 | platelet activation (GO:0030168) | 3.66021378 |
| 41 | homotypic cell-cell adhesion (GO:0034109) | 3.64466706 |
| 42 | negative regulation of response to food (GO:0032096) | 3.59538437 |
| 43 | negative regulation of appetite (GO:0032099) | 3.59538437 |
| 44 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.55206737 |
| 45 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.55093500 |
| 46 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.49538951 |
| 47 | positive regulation of blood coagulation (GO:0030194) | 3.41641486 |
| 48 | positive regulation of hemostasis (GO:1900048) | 3.41641486 |
| 49 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.39376427 |
| 50 | polyamine biosynthetic process (GO:0006596) | 3.38485494 |
| 51 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.37199088 |
| 52 | autophagic vacuole fusion (GO:0000046) | 3.36512613 |
| 53 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.32211650 |
| 54 | regulation of norepinephrine secretion (GO:0014061) | 3.24469600 |
| 55 | leukocyte degranulation (GO:0043299) | 3.23726514 |
| 56 | positive regulation of receptor recycling (GO:0001921) | 3.22163528 |
| 57 | high-density lipoprotein particle remodeling (GO:0034375) | 3.21586715 |
| 58 | regulation of female receptivity (GO:0045924) | 3.20828300 |
| 59 | negative regulation of heart contraction (GO:0045822) | 3.19439888 |
| 60 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.18893324 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.18893324 |
| 62 | regulation of memory T cell differentiation (GO:0043380) | 3.17778122 |
| 63 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.17386822 |
| 64 | regulation of mast cell activation (GO:0033003) | 3.14632554 |
| 65 | microtubule depolymerization (GO:0007019) | 3.12829689 |
| 66 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.12631410 |
| 67 | mitochondrial calcium ion transport (GO:0006851) | 3.10742569 |
| 68 | beta-amyloid metabolic process (GO:0050435) | 3.08170393 |
| 69 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04027287 |
| 70 | termination of signal transduction (GO:0023021) | 3.03192232 |
| 71 | plasma membrane fusion (GO:0045026) | 3.02487319 |
| 72 | positive regulation of coagulation (GO:0050820) | 3.02052913 |
| 73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.01336021 |
| 74 | extracellular fibril organization (GO:0043206) | 2.97344384 |
| 75 | positive regulation of granulocyte differentiation (GO:0030854) | 2.96995013 |
| 76 | reverse cholesterol transport (GO:0043691) | 2.96375522 |
| 77 | fatty acid elongation (GO:0030497) | 2.95286941 |
| 78 | negative regulation of catecholamine secretion (GO:0033604) | 2.95281272 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 2.94260969 |
| 80 | regulation of endothelial cell differentiation (GO:0045601) | 2.94237408 |
| 81 | regulation of skeletal muscle contraction (GO:0014819) | 2.94169069 |
| 82 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.92875386 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.92184133 |
| 84 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.91227274 |
| 85 | negative regulation of T cell apoptotic process (GO:0070233) | 2.90958953 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.90216228 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 2.90216228 |
| 88 | positive regulation of protein homodimerization activity (GO:0090073) | 2.89017413 |
| 89 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.85989998 |
| 90 | regulation of blood coagulation (GO:0030193) | 2.85300870 |
| 91 | regulation of hemostasis (GO:1900046) | 2.85300870 |
| 92 | endothelium development (GO:0003158) | 2.84706060 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82601355 |
| 94 | regulation of cholesterol efflux (GO:0010874) | 2.82577878 |
| 95 | cyclooxygenase pathway (GO:0019371) | 2.82186856 |
| 96 | regulation of megakaryocyte differentiation (GO:0045652) | 2.79625652 |
| 97 | regulation of regulatory T cell differentiation (GO:0045589) | 2.78714237 |
| 98 | vesicle targeting (GO:0006903) | 2.77678911 |
| 99 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.77611341 |
| 100 | peptide catabolic process (GO:0043171) | 2.77076025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 5.01406608 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.69135047 |
| 3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.26391213 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57019916 |
| 5 | GATA1_19941826_ChIP-Seq_K562_Human | 3.45357414 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.38316432 |
| 7 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.26264658 |
| 8 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.85318778 |
| 9 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.78904538 |
| 10 | GATA2_19941826_ChIP-Seq_K562_Human | 2.73442437 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.72975583 |
| 12 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.64116062 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.61811189 |
| 14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.49078076 |
| 15 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.44586391 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.42556189 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35282156 |
| 18 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.33301722 |
| 19 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.30675598 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.29448251 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.28772239 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25438504 |
| 23 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18297734 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11556093 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09142063 |
| 26 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 2.08572991 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07772762 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.96329705 |
| 29 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.88995882 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77714609 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.74960855 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67784584 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67522097 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63123905 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57999904 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57390568 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53428373 |
| 38 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50308796 |
| 39 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.48328560 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.46037624 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44138255 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42399704 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41035913 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.40268634 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.32295739 |
| 46 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.28556256 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24505901 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23946731 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22850556 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.22711001 |
| 51 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.22609784 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21598253 |
| 53 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.20949646 |
| 54 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.18408194 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17826652 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16698772 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14753768 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13433894 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12911251 |
| 60 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11311493 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10632401 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09897502 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08245860 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07862818 |
| 65 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.07353325 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06985262 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03892486 |
| 68 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03304235 |
| 69 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01624940 |
| 70 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.01508153 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99900170 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98503178 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98179668 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97752527 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97099172 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96856092 |
| 77 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96579900 |
| 78 | EWS_26573619_Chip-Seq_HEK293_Human | 0.96516551 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95777811 |
| 80 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93517947 |
| 81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92329292 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92329292 |
| 83 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.89270023 |
| 84 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88478783 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 0.87784836 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86134828 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86111780 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86023116 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85721749 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85165079 |
| 91 | MYB_26560356_Chip-Seq_TH2_Human | 0.85121085 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83683814 |
| 93 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83657121 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82859047 |
| 95 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81547647 |
| 96 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79730345 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79402111 |
| 98 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.76506535 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75678688 |
| 100 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.75295303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 9.41062560 |
| 2 | MP0008004_abnormal_stomach_pH | 4.99965238 |
| 3 | MP0003724_increased_susceptibility_to | 3.49335786 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 3.20341953 |
| 5 | MP0005083_abnormal_biliary_tract | 2.85767760 |
| 6 | MP0003303_peritoneal_inflammation | 2.76417108 |
| 7 | MP0004510_myositis | 2.45920231 |
| 8 | MP0002736_abnormal_nociception_after | 2.44782201 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.30884021 |
| 10 | MP0003136_yellow_coat_color | 2.28816920 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 2.22946276 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.20575462 |
| 13 | MP0000343_altered_response_to | 2.14344559 |
| 14 | MP0000230_abnormal_systemic_arterial | 2.05877762 |
| 15 | MP0005171_absent_coat_pigmentation | 2.05236045 |
| 16 | MP0004130_abnormal_muscle_cell | 1.92204109 |
| 17 | MP0005409_darkened_coat_color | 1.90977643 |
| 18 | MP0001968_abnormal_touch/_nociception | 1.90500672 |
| 19 | MP0004084_abnormal_cardiac_muscle | 1.83163938 |
| 20 | MP0005410_abnormal_fertilization | 1.81523856 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.69488554 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.66748349 |
| 23 | MP0008775_abnormal_heart_ventricle | 1.66416512 |
| 24 | MP0000015_abnormal_ear_pigmentation | 1.65333732 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.63349262 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.61778154 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.61488129 |
| 28 | MP0003828_pulmonary_edema | 1.56660356 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.51904905 |
| 30 | MP0002398_abnormal_bone_marrow | 1.49664338 |
| 31 | MP0003638_abnormal_response/metabolism_ | 1.49237687 |
| 32 | MP0008872_abnormal_physiological_respon | 1.45522172 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.44349587 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.44349587 |
| 35 | MP0005671_abnormal_response_to | 1.42879371 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.42228656 |
| 37 | MP0001851_eye_inflammation | 1.33307524 |
| 38 | MP0001663_abnormal_digestive_system | 1.33048173 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.31534486 |
| 40 | MP0004947_skin_inflammation | 1.30287120 |
| 41 | MP0003879_abnormal_hair_cell | 1.29513916 |
| 42 | MP0002132_abnormal_respiratory_system | 1.27624967 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.26111725 |
| 44 | MP0003436_decreased_susceptibility_to | 1.24372763 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 1.23302336 |
| 46 | MP0002723_abnormal_immune_serum | 1.16532797 |
| 47 | MP0000249_abnormal_blood_vessel | 1.16251554 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.14811351 |
| 49 | MP0001664_abnormal_digestion | 1.13653810 |
| 50 | MP0001756_abnormal_urination | 1.10007807 |
| 51 | MP0000858_altered_metastatic_potential | 1.08332893 |
| 52 | MP0002429_abnormal_blood_cell | 1.07447137 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.07074074 |
| 54 | MP0009763_increased_sensitivity_to | 1.06702733 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.05419441 |
| 56 | MP0002733_abnormal_thermal_nociception | 1.05317127 |
| 57 | MP0001800_abnormal_humoral_immune | 1.05270083 |
| 58 | MP0001765_abnormal_ion_homeostasis | 1.04637766 |
| 59 | MP0004381_abnormal_hair_follicle | 1.04147867 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.01545266 |
| 61 | MP0008874_decreased_physiological_sensi | 0.96832355 |
| 62 | MP0004215_abnormal_myocardial_fiber | 0.96073989 |
| 63 | MP0002722_abnormal_immune_system | 0.95267359 |
| 64 | MP0009642_abnormal_blood_homeostasis | 0.94878308 |
| 65 | MP0006276_abnormal_autonomic_nervous | 0.94557438 |
| 66 | MP0009764_decreased_sensitivity_to | 0.93468536 |
| 67 | MP0002420_abnormal_adaptive_immunity | 0.92720678 |
| 68 | MP0001533_abnormal_skeleton_physiology | 0.92441089 |
| 69 | MP0001819_abnormal_immune_cell | 0.91123229 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 0.88600878 |
| 71 | MP0000716_abnormal_immune_system | 0.87755795 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 0.86621661 |
| 73 | MP0002735_abnormal_chemical_nociception | 0.86205751 |
| 74 | MP0001970_abnormal_pain_threshold | 0.85908042 |
| 75 | MP0005666_abnormal_adipose_tissue | 0.84375517 |
| 76 | MP0005501_abnormal_skin_physiology | 0.84109873 |
| 77 | MP0001845_abnormal_inflammatory_respons | 0.83755388 |
| 78 | MP0002419_abnormal_innate_immunity | 0.82078068 |
| 79 | MP0003866_abnormal_defecation | 0.80609689 |
| 80 | MP0005381_digestive/alimentary_phenotyp | 0.79018467 |
| 81 | MP0009278_abnormal_bone_marrow | 0.77959848 |
| 82 | MP0005025_abnormal_response_to | 0.75868245 |
| 83 | MP0005423_abnormal_somatic_nervous | 0.74122395 |
| 84 | MP0005535_abnormal_body_temperature | 0.73986669 |
| 85 | MP0003718_maternal_effect | 0.73982574 |
| 86 | MP0003045_fibrosis | 0.73390662 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.73237983 |
| 88 | MP0005023_abnormal_wound_healing | 0.71395799 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 0.68979357 |
| 90 | MP0004484_altered_response_of | 0.68820507 |
| 91 | MP0005385_cardiovascular_system_phenoty | 0.68815171 |
| 92 | MP0001544_abnormal_cardiovascular_syste | 0.68815171 |
| 93 | MP0001661_extended_life_span | 0.68269002 |
| 94 | MP0001188_hyperpigmentation | 0.68062720 |
| 95 | MP0003448_altered_tumor_morphology | 0.67823027 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.67231074 |
| 97 | MP0006054_spinal_hemorrhage | 0.66811930 |
| 98 | MP0000358_abnormal_cell_content/ | 0.64503639 |
| 99 | MP0000685_abnormal_immune_system | 0.64219643 |
| 100 | MP0002972_abnormal_cardiac_muscle | 0.64011058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.88138481 |
| 2 | Petechiae (HP:0000967) | 9.68091814 |
| 3 | Abnormal platelet volume (HP:0011876) | 9.34033252 |
| 4 | Purpura (HP:0000979) | 8.42798742 |
| 5 | Epistaxis (HP:0000421) | 7.76962098 |
| 6 | Gingival bleeding (HP:0000225) | 6.64917631 |
| 7 | Dyschromatopsia (HP:0007641) | 6.22129126 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.90968492 |
| 9 | Impaired platelet aggregation (HP:0003540) | 5.73722456 |
| 10 | Abnormal platelet function (HP:0011869) | 5.73722456 |
| 11 | Poikilocytosis (HP:0004447) | 4.50915773 |
| 12 | Acanthocytosis (HP:0001927) | 4.39422846 |
| 13 | Spontaneous hematomas (HP:0007420) | 4.07837505 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.98496838 |
| 15 | Decreased central vision (HP:0007663) | 3.83273984 |
| 16 | Bruising susceptibility (HP:0000978) | 3.50871995 |
| 17 | Abnormal pupillary function (HP:0007686) | 3.43102858 |
| 18 | Joint hemorrhage (HP:0005261) | 3.37470894 |
| 19 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.29672687 |
| 20 | Paralysis (HP:0003470) | 3.27019949 |
| 21 | Conjunctival telangiectasia (HP:0000524) | 3.10008231 |
| 22 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.75282187 |
| 23 | Tinnitus (HP:0000360) | 2.71606786 |
| 24 | Abnormal auditory evoked potentials (HP:0006958) | 2.69795571 |
| 25 | Male infertility (HP:0003251) | 2.69196260 |
| 26 | Spontaneous abortion (HP:0005268) | 2.59947820 |
| 27 | Abnormality of lateral ventricle (HP:0030047) | 2.57117343 |
| 28 | Increased density of long bones (HP:0006392) | 2.53142268 |
| 29 | Generalized aminoaciduria (HP:0002909) | 2.39591400 |
| 30 | Upper limb muscle weakness (HP:0003484) | 2.38657833 |
| 31 | Abnormality of iron homeostasis (HP:0011031) | 2.35971425 |
| 32 | Xanthomatosis (HP:0000991) | 2.34496871 |
| 33 | Joint swelling (HP:0001386) | 2.33639187 |
| 34 | Hepatosplenomegaly (HP:0001433) | 2.28116300 |
| 35 | Hypophosphatemic rickets (HP:0004912) | 2.25201089 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15307077 |
| 37 | Stomatitis (HP:0010280) | 2.14163187 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.10609022 |
| 39 | Increased IgM level (HP:0003496) | 2.06096456 |
| 40 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05556413 |
| 41 | Arterial thrombosis (HP:0004420) | 2.05267328 |
| 42 | Papillary thyroid carcinoma (HP:0002895) | 2.04519609 |
| 43 | Prolonged bleeding time (HP:0003010) | 11.2679278 |
| 44 | Menorrhagia (HP:0000132) | 10.1120841 |
| 45 | Rectovaginal fistula (HP:0000143) | 1.99038296 |
| 46 | Rectal fistula (HP:0100590) | 1.99038296 |
| 47 | Attenuation of retinal blood vessels (HP:0007843) | 1.97652204 |
| 48 | Thyroid-stimulating hormone excess (HP:0002925) | 1.88303502 |
| 49 | Nausea (HP:0002018) | 1.87937286 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 1.84658646 |
| 51 | Renal Fanconi syndrome (HP:0001994) | 1.83268403 |
| 52 | Thrombocytosis (HP:0001894) | 1.80918735 |
| 53 | Increased serum ferritin (HP:0003281) | 1.80369973 |
| 54 | Intestinal fistula (HP:0100819) | 1.76271046 |
| 55 | Hyperthyroidism (HP:0000836) | 1.73638506 |
| 56 | Encephalitis (HP:0002383) | 1.72519080 |
| 57 | Episodic fever (HP:0001954) | 1.71603197 |
| 58 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.67849806 |
| 59 | Abnormality of alanine metabolism (HP:0010916) | 1.67623126 |
| 60 | Hyperalaninemia (HP:0003348) | 1.67623126 |
| 61 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.67623126 |
| 62 | 3-Methylglutaconic aciduria (HP:0003535) | 1.66376346 |
| 63 | Hemorrhage of the eye (HP:0011885) | 1.63100655 |
| 64 | Biliary tract neoplasm (HP:0100574) | 1.62721920 |
| 65 | Basal ganglia calcification (HP:0002135) | 1.62277823 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 1.61105335 |
| 67 | Obstructive lung disease (HP:0006536) | 1.61105335 |
| 68 | Infertility (HP:0000789) | 1.60025198 |
| 69 | Vaginal fistula (HP:0004320) | 1.59665837 |
| 70 | Facial diplegia (HP:0001349) | 1.59100601 |
| 71 | Tongue fasciculations (HP:0001308) | 1.57989508 |
| 72 | Abnormality of the costochondral junction (HP:0000919) | 1.56676446 |
| 73 | Chest pain (HP:0100749) | 1.54992277 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 1.54649958 |
| 75 | Dysautonomia (HP:0002459) | 1.53016855 |
| 76 | Choroideremia (HP:0001139) | 1.52460124 |
| 77 | Exertional dyspnea (HP:0002875) | 1.50592431 |
| 78 | Abnormality of the prostate (HP:0008775) | 1.49802139 |
| 79 | Abnormal ciliary motility (HP:0012262) | 1.49250778 |
| 80 | Testicular neoplasm (HP:0010788) | 1.49205596 |
| 81 | Abnormality of the hepatic vasculature (HP:0006707) | 1.48193193 |
| 82 | Ventricular fibrillation (HP:0001663) | 1.48176242 |
| 83 | Vertigo (HP:0002321) | 1.46779614 |
| 84 | Polycythemia (HP:0001901) | 1.46346198 |
| 85 | Muscle fibrillation (HP:0010546) | 1.45764195 |
| 86 | Myocardial infarction (HP:0001658) | 1.45093669 |
| 87 | Congenital stationary night blindness (HP:0007642) | 1.45030414 |
| 88 | Hypertriglyceridemia (HP:0002155) | 1.43256691 |
| 89 | Polyphagia (HP:0002591) | 1.40845509 |
| 90 | Ileus (HP:0002595) | 1.39372353 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 1.39240878 |
| 92 | Central scotoma (HP:0000603) | 1.38905095 |
| 93 | Thrombophlebitis (HP:0004418) | 1.37051949 |
| 94 | Dysostosis multiplex (HP:0000943) | 1.35920154 |
| 95 | Poikiloderma (HP:0001029) | 1.34920686 |
| 96 | Uterine leiomyosarcoma (HP:0002891) | 1.32218632 |
| 97 | Leiomyosarcoma (HP:0100243) | 1.32218632 |
| 98 | Facial hemangioma (HP:0000329) | 1.32011283 |
| 99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.31701990 |
| 100 | Congenital sensorineural hearing impairment (HP:0008527) | 1.30225010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.10992929 |
| 2 | MST4 | 4.77464593 |
| 3 | BMX | 4.31191136 |
| 4 | MYLK | 3.51420438 |
| 5 | BTK | 3.11692425 |
| 6 | TEC | 3.08341393 |
| 7 | EIF2AK1 | 2.87127932 |
| 8 | PTK2B | 2.54449403 |
| 9 | TAOK3 | 2.43448376 |
| 10 | SYK | 2.38099402 |
| 11 | ZAP70 | 2.26417910 |
| 12 | CSF1R | 2.24372214 |
| 13 | ACVR1B | 2.22068452 |
| 14 | PIK3CG | 2.21009553 |
| 15 | GRK6 | 2.16089480 |
| 16 | BMPR2 | 1.93220359 |
| 17 | GRK5 | 1.92140017 |
| 18 | STK3 | 1.88573867 |
| 19 | BLK | 1.75990090 |
| 20 | ILK | 1.68912212 |
| 21 | HCK | 1.52244479 |
| 22 | ADRBK2 | 1.52109419 |
| 23 | MAP2K3 | 1.50340469 |
| 24 | FGR | 1.35107055 |
| 25 | TNK2 | 1.33384855 |
| 26 | TESK2 | 1.30933943 |
| 27 | FES | 1.29035469 |
| 28 | TLK1 | 1.22489815 |
| 29 | NUAK1 | 1.18429791 |
| 30 | LYN | 1.17480416 |
| 31 | PAK1 | 1.13882872 |
| 32 | BMPR1B | 1.12583779 |
| 33 | MAPKAPK3 | 1.12348107 |
| 34 | IKBKB | 1.12009988 |
| 35 | MAPK15 | 1.05041706 |
| 36 | ADRBK1 | 1.04928994 |
| 37 | TNIK | 1.02990816 |
| 38 | LMTK2 | 1.02460867 |
| 39 | DAPK3 | 1.00808050 |
| 40 | IRAK1 | 0.99402124 |
| 41 | MATK | 0.97123887 |
| 42 | TXK | 0.95658487 |
| 43 | PNCK | 0.93330283 |
| 44 | ITK | 0.90819432 |
| 45 | WNK4 | 0.90817351 |
| 46 | PDPK1 | 0.87109037 |
| 47 | SIK3 | 0.85433699 |
| 48 | PLK2 | 0.83184562 |
| 49 | RET | 0.82781560 |
| 50 | PRKD1 | 0.81843382 |
| 51 | STK24 | 0.79633655 |
| 52 | PDK1 | 0.79153613 |
| 53 | CSK | 0.76407134 |
| 54 | TRIM28 | 0.75579098 |
| 55 | MAP3K5 | 0.73877719 |
| 56 | IRAK2 | 0.72266486 |
| 57 | DAPK2 | 0.71711980 |
| 58 | PIM2 | 0.71271356 |
| 59 | MAPK12 | 0.66995987 |
| 60 | MARK3 | 0.65453134 |
| 61 | MAP4K2 | 0.60566393 |
| 62 | MAP2K1 | 0.60146783 |
| 63 | ZAK | 0.55799724 |
| 64 | STK4 | 0.53051340 |
| 65 | ERBB2 | 0.51830016 |
| 66 | EPHA3 | 0.51719663 |
| 67 | LCK | 0.51416131 |
| 68 | PRKACG | 0.50886971 |
| 69 | TAOK2 | 0.47884160 |
| 70 | FER | 0.43987186 |
| 71 | PKN1 | 0.43858077 |
| 72 | IRAK3 | 0.40858964 |
| 73 | MINK1 | 0.40328760 |
| 74 | PRKG1 | 0.40328259 |
| 75 | PRKCQ | 0.40233232 |
| 76 | MUSK | 0.39868790 |
| 77 | JAK3 | 0.37364618 |
| 78 | FYN | 0.36240481 |
| 79 | PDGFRB | 0.36097645 |
| 80 | MAP3K3 | 0.35715142 |
| 81 | DAPK1 | 0.35042044 |
| 82 | CDK14 | 0.32475630 |
| 83 | SGK2 | 0.32156355 |
| 84 | PRKCD | 0.31131545 |
| 85 | MAP4K1 | 0.29245674 |
| 86 | MAPK13 | 0.28942846 |
| 87 | JAK2 | 0.28231701 |
| 88 | PRKCA | 0.26138024 |
| 89 | SRC | 0.24487835 |
| 90 | PRKCB | 0.24484586 |
| 91 | SGK3 | 0.24234350 |
| 92 | CAMKK2 | 0.23831140 |
| 93 | IRAK4 | 0.23413293 |
| 94 | MAPK11 | 0.23264214 |
| 95 | GRK1 | 0.23247376 |
| 96 | DYRK1B | 0.22861631 |
| 97 | ROCK1 | 0.21326076 |
| 98 | PIM1 | 0.21201421 |
| 99 | HIPK2 | 0.20897092 |
| 100 | YES1 | 0.18507105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.65691198 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.28760846 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.03336494 |
| 4 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.49961856 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.44353466 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.27382140 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.06739760 |
| 8 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.06470844 |
| 9 | Gap junction_Homo sapiens_hsa04540 | 2.02143021 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.78992422 |
| 11 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.76345188 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64956790 |
| 13 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.60523747 |
| 14 | Alcoholism_Homo sapiens_hsa05034 | 1.57466291 |
| 15 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.55539281 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51940707 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.50870021 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48666684 |
| 19 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.39723339 |
| 20 | Endocytosis_Homo sapiens_hsa04144 | 1.38074796 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31072605 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30286925 |
| 23 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.28688156 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17698360 |
| 25 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13561667 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.12813800 |
| 27 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09710616 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08911377 |
| 29 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05067157 |
| 30 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04673810 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04015861 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00500779 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 0.96329942 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95965750 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94250247 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93987392 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88878992 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88197488 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88061172 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84108361 |
| 41 | Malaria_Homo sapiens_hsa05144 | 0.83245552 |
| 42 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81069578 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80880359 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80873616 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77837336 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76656788 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 0.76338949 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75787654 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75415056 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75392540 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73527841 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73497471 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72941572 |
| 54 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72876499 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72480473 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70058120 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69781097 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68262609 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.67943476 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.66912598 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65512909 |
| 62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64746278 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.64318999 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62798130 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59883268 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58613490 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57759804 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55671175 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55668517 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55278231 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55275333 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53956344 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53369021 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48591566 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47566810 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.47484274 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45660845 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.44334153 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44222583 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.44040228 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43822830 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41929708 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40412163 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39825162 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39777968 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38960043 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37343493 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37274949 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.36858263 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36803712 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36569021 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.36506383 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35844108 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35362240 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.35217520 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34876399 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.33004582 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32527480 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32259981 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.32225313 |

